Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes.

Source:http://linkedlifedata.com/resource/pubmed/id/9626198

Download in:

View as

General Info

PMID
9626198